Cited by 1043D Printing in Biomedical ResearchTissue Engineering and Regenerative MedicineSkin and Cellular Biology Research

Next generation human skin constructs as advanced tools for drug development

Open access
Abaci, HE, Guo, Zongyou, Doucet, Yanne, Jacków, Joanna, Christiano, Angela·2017·Experimental Biology and Medicine

Abstract

Many diseases, as well as side effects of drugs, manifest themselves through skin symptoms. Skin is a complex tissue that hosts various specialized cell types and performs many roles including physical barrier, immune and sensory functions. Therefore, modeling skin in vitro presents technical challenges for tissue engineering. Since the first attempts at engineering human epidermis in 1970s, there has been a growing interest in generating full-thickness skin constructs mimicking physiological functions by incorporating various skin components, such as vasculature and melanocytes for pigmentation. Development of biomimetic in vitro human skin models with these physiological functions provides a new tool for drug discovery, disease modeling, regenerative medicine and basic research for skin biology. This goal, however, has long been delayed by the limited availability of different cell types, the challenges in establishing co-culture conditions, and the ability to recapitulate the 3D anatomy of the skin. Recent breakthroughs in induced pluripotent stem cell (iPSC) technology and microfabrication techniques such as 3D-printing have allowed for building more reliable and complex in vitro skin models for pharmaceutical screening. In this review, we focus on the current developments and prevailing challenges in generating skin constructs with vasculature, skin appendages such as hair follicles, pigmentation, immune response, innervation, and hypodermis. Furthermore, we discuss the…

Integrity signals

Registry

Crossref · 10.1177/1535370217712690

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 125 · Cited by 104

Authors
Abaci, H., Guo, Z., Doucet, Y., Jacków, J., & Christiano, A.
Affiliations
  • Columbia University Irving Medical Center (US)
  • Department of Dermatology, Columbia University Medical Center, New York, NY 10032, USA
Corresponding author
Christiano, Angela
Venue
Experimental Biology and Medicine
Published
2017-06-07
Volume
242
Issue
17
Pages
1657-1668
ISSN
  • 0071-3384 (ISSN-L)
  • 1535-3702
  • 1535-3699
OpenAlex
W2622369378
Cited by
104
References
125
Citations by year
2026: 7 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 11 · 2021: 15 · 2020: 15 · 2019: 13 · 2018: 13 · 2017: 4
FWCI
5.54
Type
journal article
Language
en
Open access
Locations
  • Experimental Biology and Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
Funders
National Center for Advancing Translational Sciences (3UH3EB017103-04S2)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
Keywords
in vitro skin model, induced pluripotent stem cells, drug screening, epidermolysis bullosa, psoriasis, organ-on-a-chip, skin vasculature, hair follicle, melanocytes, skin pigmentation, skin innervation, subcutaneous tissue, co-culture, high-throughput drug screening
MeSH terms
Humans, Skin, Skin Diseases, Tissue Engineering, Microfluidics, Regenerative Medicine, Microchip Analytical Procedures, Drug Discovery, Lab-On-A-Chip Devices, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review